Our Sponsors

EU-PFF was founded on an ethos of collaboration and co-operation. We are proud to gratefully acknowledge the partnership, financial support and commitment to our patient community given by all of our sponsors.

Gold Sponsors

is researching multiple mechanisms and approaches, with the goal of helping those living with IPF and other forms of lung fibrosis.

Silver Sponsors

is dedicated to restoring organ function by developing therapies that modulate growth factors. With a focus on treating fibrosis, Agomab is advancing a pipeline of innovative treatments aimed at improving patients’ lives.

is focused on the development and commercialisation of an oral therapy for the treatment of chronic cough in IPF and other chronic cough conditions.

is committed to working closely with the patient community and with scientific experts and clinicians to find innovative solutions that meet the needs of these patients.

Bronze Sponsors

is a global biopharma company dedicated to developing innovative medicines and vaccines that help people do more, feel better, and live longer. With a strong focus on respiratory diseases, GSK is committed to advancing research in pulmonary fibrosis and other serious conditions to improve patient outcomes.

is a clinical-stage biotech company developing transformative treatments for life-threatening diseases. They’re working on innovative therapies for conditions like idiopathic pulmonary fibrosis and various cancers, aiming to bring new hope to patients.

Want to support our cause?

We need your active help and participation in raising awareness of PF to shape healthcare policy, treatment, care and research in favour of Pulmonary Fibrosis patients in Europe and beyond.

Get Involved Now!